Bamco Inc. NY Has $76.32 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bamco Inc. NY decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 146,216 shares of the medical equipment provider's stock after selling 14,009 shares during the quarter. Bamco Inc. NY's holdings in Intuitive Surgical were worth $76,319,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Bennett Selby Investments LP raised its position in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after buying an additional 17 shares during the period. Onefund LLC increased its position in shares of Intuitive Surgical by 1.9% during the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after acquiring an additional 18 shares during the last quarter. LVW Advisors LLC grew its stake in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. increased its stake in shares of Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after buying an additional 19 shares during the last quarter. Finally, FSM Wealth Advisors LLC increased its position in shares of Intuitive Surgical by 3.7% in the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock worth $275,000 after purchasing an additional 19 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Jamie Samath sold 269 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the sale, the chief financial officer now owns 3,282 shares in the company, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 33,313 shares of company stock valued at $17,229,143. 0.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Leerink Partners increased their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Jefferies Financial Group increased their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Citigroup increased their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research report on Friday, January 24th. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Finally, Raymond James lifted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $598.95.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded up $5.69 during trading hours on Wednesday, hitting $536.15. 1,311,349 shares of the company's stock were exchanged, compared to its average volume of 1,626,933. The company's 50-day moving average price is $502.67 and its 200-day moving average price is $534.43. The stock has a market capitalization of $192.17 billion, a price-to-earnings ratio of 83.64, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1-year low of $379.67 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the firm posted $1.50 EPS. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.